Abstract 153: The Effect of Aspirin on Aneurysm Wall Enhancement: A Study in Rabbits and Humans
Aneurysm wall enhancement (AWE) is a potential biomarker of inflammation within the aneurysm wall. Aspirin (ASA) may decrease AWE due to its anti‐inflammatory properties. We aimed to assess the effect of ASA on AWE in an animal model and a prospectively acquired cohort of patients with unruptured intracranial aneurysms (UIAs).
Authors
- David Hasan (ORCID: https://orcid.org/0000-0002-8335-5442)
- Vance T. Lehman (ORCID: https://orcid.org/0000-0002-8713-8293)
- Diego Ojeda (ORCID: https://orcid.org/0000-0001-6528-6087)
- Edgar Andres Samaniego (ORCID: https://orcid.org/0000-0003-2764-2268)
- Ramanthan Kadiervel
- Andres S Gudino (ORCID: https://orcid.org/0009-0003-0123-6138)
- Carlos Dier (ORCID: https://orcid.org/0009-0009-8243-9087)
- N. Shenoy
- Elena Sagues Sese
Institutions
- University of Calicut (IN)
- Duke University (US)
- University of Iowa Hospitals and Clinics (US)
- WinnMed (US)
- Mayo Clinic in Arizona (US)
Publication Details
- Journal
- Stroke Vascular and Interventional Neurology
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1161/svin.04.suppl_1.153
- Primary Topic
- Intracranial Aneurysms: Treatment and Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.00